Netter-1 Phase Iii: Efficacy And Safety Results In Patients With Midgut Neuroendocrine Tumors Treated With Lu-177-Dotatate

JOURNAL OF CLINICAL ONCOLOGY(2016)

Cited 3|Views2
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined